Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
267.45
|
|
Change (%)
|
-2.25 (-0.83%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
265.30
-
274.40
|
|
52-Week Range (RS)
|
105.05
-
280.20
|
|
Beta (1 Year)
|
NA
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Bliss GVS Pharma to declare Quarterly Results |
| Board of Bliss GVS Pharma recommends interim dividend |
| Bliss GVS Pharma to conduct board meeting |
|
|
|
| Incoporation Year : 1984 |
| Chairman : Nandkumar Kashinath Chodankar |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Bliss GVS Pharma Ltd
102 Hyde Park Sakivihar Road,
Andheri East,
Mumbai,
Maharashtra-400072 |
Phone:91-22-42160000
Fax:91-22-28563930 |
| E-Mail : cs@blissgvs.com; info@blissgvs.com |
| URL : http://www.blissgvs.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
29-Apr-2026 |
267.75 |
-0.11 |
| 1Month |
06-Apr-2026 |
237.00 |
12.85 |
| 3Month |
06-Feb-2026 |
183.50 |
45.75 |
| 6Month |
06-Nov-2025 |
151.90 |
76.07 |
| 1Year |
06-May-2025 |
113.50 |
135.64 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Motilal Oswal BSE Healthcare ETF |
0.11 |
0.04 |
| Bandhan BSE Healthcare Index Fund |
0.11 |
0.02 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
4,357.50 |
1.91 |
4,479.70 |
3,101.00 |
147,477.60 |
| Ajanta Pharma Ltd |
3,093.25 |
6.63 |
3,158.20 |
2,335.00 |
38,645.71 |
| Gland Pharma Ltd |
1,812.55 |
2.22 |
2,130.00 |
1,382.75 |
29,862.92 |
| ERIS Lifesciences Ltd |
1,371.50 |
1.00 |
1,909.55 |
1,237.90 |
19,001.16 |
| Rubicon Research Ltd |
999.10 |
3.91 |
1,010.00 |
571.00 |
16,460.20 |
|
|
|
|